ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 410 filers reported holding ENCOMPASS HEALTH CORP in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,645,410 | +1.1% | 173,398 | +1.9% | 0.28% | +9.5% |
| Q2 2023 | $11,516,252 | -29.1% | 170,082 | -43.4% | 0.25% | -24.0% |
| Q1 2023 | $16,246,501 | +5.6% | 300,305 | +16.8% | 0.33% | -6.5% |
| Q4 2022 | $15,378,586 | +101.6% | 257,124 | +52.5% | 0.36% | +87.4% |
| Q3 2022 | $7,628,000 | +199.3% | 168,648 | +270.8% | 0.19% | +183.6% |
| Q2 2022 | $2,549,000 | +196.1% | 45,483 | +275.8% | 0.07% | +235.0% |
| Q1 2022 | $861,000 | +212.0% | 12,104 | +228.7% | 0.02% | +150.0% |
| Q3 2021 | $276,000 | -94.1% | 3,682 | -93.8% | 0.01% | -94.6% |
| Q2 2021 | $4,639,000 | +193.8% | 59,457 | +208.3% | 0.15% | +152.5% |
| Q1 2021 | $1,579,000 | +72.2% | 19,283 | +73.8% | 0.06% | +73.5% |
| Q4 2020 | $917,000 | -72.6% | 11,092 | -78.5% | 0.03% | -83.2% |
| Q3 2020 | $3,345,000 | +1116.4% | 51,474 | +1082.8% | 0.20% | +708.0% |
| Q3 2019 | $275,000 | – | 4,352 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |